Compare · SMX vs TMO
SMX vs TMO
Side-by-side comparison of SMX (Security Matters) Public Limited Company (SMX) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- SMX operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $223.02B, about 11627.2x SMX ($19.2M).
- Over the past year, SMX is down 99.9% and TMO is up 22.8% - TMO leads by 122.8 points.
- TMO has been more active in the news (14 items in the past 4 weeks vs 13 for SMX).
- TMO has more recent analyst coverage (25 ratings vs 0 for SMX).
- Company
- SMX (Security Matters) Public Limited Company
- Thermo Fisher Scientific Inc
- Price
- $17.41+0.40%
- $603.37-0.46%
- Market cap
- $19.2M
- $223.02B
- 1M return
- +7.50%
- -0.24%
- 1Y return
- -99.94%
- +22.82%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 13
- 14
- Recent ratings
- 0
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest SMX
- SEC Form 6-K filed by SMX (Security Matters) Public Limited Company
- SMX Gives Material a Material; Digital Platform Makes Plastic a Passport and a Tradable Asset
- SMX Unveils Four-Layer Digital Platform for Plastics, Connecting Physical Material to Digital Passports, Markets and Credits
- The Age of Parity Has a Passport; SMX Provides the Stamp
- Recycling is No Longer a Favor to the Planet. It's an Economic Must
- The Age of Parity Makes Affordability Real
- SMX Can Prove "Made in America" is Great Again; The Age of Parity Is Making it Time
- Luxury Has An Authentication Problem; SMX Is Putting The Proof Inside The Product
- Silver's Surge and Supply Pressures Create a New Imperative for Certification; SMX Invented the Technology That Does It
- Digital Product Passports Move From Concept to Reality, SMX Brings Physical Materials Into the Digital Economy
Latest TMO
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)
- SVP and General Counsel Shropshire Thomas B Jr. covered exercise/tax liability with 49 shares, decreasing direct ownership by 0.81% to 6,008 units (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. covered exercise/tax liability with 394 shares, decreasing direct ownership by 3% to 14,391 units (SEC Form 4)
- Sr. Vice President & CFO Meyer James covered exercise/tax liability with 270 shares, decreasing direct ownership by 5% to 5,560 units (SEC Form 4)
- Chairman & CEO Casper Marc N covered exercise/tax liability with 1,257 shares, decreasing direct ownership by 1% to 122,669 units (SEC Form 4)
- VP & Chief Accounting Officer Holmes Joseph R. covered exercise/tax liability with 50 shares, decreasing direct ownership by 2% to 2,916 units (SEC Form 4)
- President & COO Pettiti Gianluca covered exercise/tax liability with 1,035 shares, sold $2,539,233 worth of shares (4,133 units at $614.38) as part of a pre-agreed trading plan and exercised 3,733 shares at a strike of $309.63, decreasing direct ownership by 6% to 23,216 units (SEC Form 4)
- Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026